EMA issues recommendation of Leqembi for treatment of early Alzheimer’s disease
The human medicines committee (CHMP) at the European Medicines Agency concluded that, in the restricted population assessed, the benefits of…
EMA: Use of opioids with weight loss medicine Mysimba may lead to serious side effects
Opioid medicines may not work effectively in patients taking Mysimba, because one of the active substances in Mysimba, naltrexone, blocks the effects…
EU Auditors: EU medical agencies need a booster to prepare for the next pandemic
The health crisis caused by the COVID-19 pandemic caught the EU partially off guard. Even though the two EU medical…
Common respiratory virus: EU Commission authorises mRNA vaccine
The EU Commission has authorised the mRNA vaccine ‘mResvia', to immunise adults over 60 years of age against lower respiratory tract disease, which…